I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
A cell permeable and selective inhibitor of the cyclin-dependent kinases Cdk1/cyclin B, Cdk2 and Cdk5. The inhibitory effect butyrolactone I is due to competition with ATP binding at the Cdk. Butyrolactone I inhibits cell cycle progression at the G1/S and G2/M transitions. Butyrolactone I also blocks Fas-induced apoptosis.
A tool for probing the cellular roles of cyclin-dependent kinases. A selective inhibitor of CDK1/cyclin B, CDK2 and CDK5.
Gefahrenhinweise (EU): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.